Sanofi
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria… Read more
Sanofi (SNYNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.100x
Based on the latest financial reports, Sanofi (SNYNF) has a cash flow conversion efficiency ratio of 0.100x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.19 Billion) by net assets ($71.68 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sanofi - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Sanofi's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sanofi Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sanofi ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Agnico Eagle Mines Limited
NYSE:AEM
|
0.077x |
|
Newmont Corporation
AU:NEM
|
0.110x |
|
Boston Scientific Corp
NYSE:BSX
|
0.057x |
|
Lockheed Martin Corporation
NYSE:LMT
|
0.603x |
|
Kweichow Moutai Co Ltd
SHG:600519
|
0.095x |
|
Constellation Energy Corp
NASDAQ:CEG
|
0.054x |
|
Adobe Inc.
LSE:0R2Y
|
0.189x |
|
Adobe Systems Incorporated
NASDAQ:ADBE
|
0.272x |
Annual Cash Flow Conversion Efficiency for Sanofi (1999–2025)
The table below shows the annual cash flow conversion efficiency of Sanofi from 1999 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $71.68 Billion | $10.75 Billion | 0.150x | +28.53% |
| 2024-12-31 | $77.86 Billion | $9.08 Billion | 0.117x | -15.46% |
| 2023-12-31 | $74.35 Billion | $10.26 Billion | 0.138x | -1.50% |
| 2022-12-31 | $75.15 Billion | $10.53 Billion | 0.140x | -8.11% |
| 2021-12-31 | $69.03 Billion | $10.52 Billion | 0.152x | +29.75% |
| 2020-12-31 | $63.15 Billion | $7.42 Billion | 0.117x | -10.00% |
| 2019-12-31 | $59.11 Billion | $7.71 Billion | 0.131x | +38.91% |
| 2018-12-31 | $59.03 Billion | $5.55 Billion | 0.094x | -25.82% |
| 2017-12-31 | $58.26 Billion | $7.38 Billion | 0.127x | -6.72% |
| 2016-12-31 | $57.72 Billion | $7.84 Billion | 0.136x | -11.39% |
| 2015-12-31 | $58.21 Billion | $8.92 Billion | 0.153x | +12.12% |
| 2014-12-31 | $56.27 Billion | $7.69 Billion | 0.137x | +12.05% |
| 2013-12-31 | $57.01 Billion | $6.95 Billion | 0.122x | -14.21% |
| 2012-12-31 | $57.47 Billion | $8.17 Billion | 0.142x | -13.97% |
| 2011-12-31 | $56.39 Billion | $9.32 Billion | 0.165x | -9.76% |
| 2010-12-31 | $53.29 Billion | $9.76 Billion | 0.183x | +4.20% |
| 2009-12-31 | $48.45 Billion | $8.52 Billion | 0.176x | -7.05% |
| 2008-12-31 | $45.07 Billion | $8.52 Billion | 0.189x | +19.00% |
| 2007-12-31 | $44.79 Billion | $7.12 Billion | 0.159x | +10.25% |
| 2006-12-31 | $45.82 Billion | $6.60 Billion | 0.144x | +5.49% |
| 2005-12-31 | $46.79 Billion | $6.39 Billion | 0.137x | +21.90% |
| 2004-12-31 | $35.92 Billion | $4.03 Billion | 0.112x | -68.63% |
| 2003-12-31 | $6.33 Billion | $2.26 Billion | 0.357x | +29.04% |
| 2002-12-31 | $6.06 Billion | $1.68 Billion | 0.277x | -11.84% |
| 2001-12-31 | $5.79 Billion | $1.82 Billion | 0.314x | +13.46% |
| 2000-12-31 | $4.33 Billion | $1.20 Billion | 0.277x | +20.71% |
| 1999-12-31 | $3.61 Billion | $828.00 Million | 0.229x | -- |